Find and Pitch Jounalists, Get Your Story Covered

Tags: psoriasis scalp psoriasis dermatology eclampsia small for gestational age

	Profile	Recent Articles on Subject
1	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Lupus Patients See More Vascular Risk, but It's Modifiable - about 1 month ago Psoriasis Joins List of Diseases Tied to Air Pollution - 7 months ago Genes, Air Pollution Combine to Raise Lupus Risk - 7 months ago Study Confirms: No Great Options for Treating VEXAS - 8 months ago Psoriatic Arthritis: Updated Guideline Clarifies Treatment Sequence - 11 months ago PsA Raises Mortality Risk, but Unevenly - about 1 year ago Novel IL-17A Blocker Continues to Impress in PsA - about 1 year ago
2	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Bristol Myers Squibb’s Sotyktu Meets Goals in Two Pivotal Psoriatic Arthritis Studies - about 1 month ago Inflammation Biotech Alumis Trims IPO Plans But Still Raises $250M for Clinical Trials - 7 months ago
3	Karmela Padavic-Callaghan New Scientist Science writer. Physics PhD. science writingphysics	How your mental state and stress levels influence your skin - about 1 month ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Ustekinumab-stba Receives FDA Approval for Autoimmune Disorder and Inflammatory Bowel Disease - about 1 month ago
5	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	Alpha-Gal May Drive Sensitivity to IV Stelara in People With Red-Meat Allergies - about 2 months ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Ustekinumab-kfce as Biosimilar to Ustekinumab - 2 months ago FDA Grants Orphan Drug Designation to AISA-021 for Systemic Sclerosis - 5 months ago Study: Lebrikizumab Demonstrates Improvements in Atopic Dermatitis for Patients of Color - 11 months ago Study: SB17 Shows Biosimilarity to Ustekinumab for Plaque Psoriasis - 11 months ago Study: IL-23 Inhibitors Associated With Lowest Risk of Paradoxical Eczema in Patients With Plaque Psoriasis - about 1 year ago TAK-279 Demonstrates Improvements in ACR 20 Response for Psoriatic Arthritis - about 1 year ago
7	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Lebrikizumab Wins FDA Approval for Eczema - 5 months ago
8	Carly Cassella Science Alert Writer at ScienceAlert. Sciencewriting	Root Cause of Lupus Found in a 'Tug-of-War' Over a Critical White Cell - 7 months ago
9	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Investors funnel $275 million into Paragon Therapeutics spinout - 10 months ago
10	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS - 10 months ago

Journalists covering psoriasis